美国符合血管外科学会腹主动脉瘤指南的中心比例下降
基于血管质量倡议2011至2019年数据,评估美国336家机构中符合SVS主动脉指南的中心比例变化。EVAR符合中心比例每年增1.7%,从51.6%升至67.1%;OAR符合中心比例每年降1.8%,从32.8%降至16.3%;两者均符合的中心比例从26.6%降至13.1%。
要点
- EVAR符合SVS指南的中心比例从2011年51.6%升至2019年67.1%,年增1.7%。
- OAR符合SVS指南的中心比例从2011年32.8%降至2019年16.3%,年降1.8%。
- 同时符合EVAR和OAR指南的中心比例从26.6%降至13.1%,2019年各地区无显著差异(P = .82)。
核心结论
- 全国范围内符合SVS指南的EVAR中心比例增加,但符合OAR指南的中心比例较小且呈令人担忧的下降趋势。
- 这些数据对大多数机构能否安全提供OAR提出疑问,对受训者获得足够OAR暴露有重要影响,并支持OAR的区域化。
研究设计与样本
- 基于SVS血管质量倡议数据库2011至2019年所有OAR、主动脉旁路和EVAR的回顾性分析,共纳入336家机构的67,865例患者(EVAR 49,264例;OAR 11,010例;主动脉旁路7,591例)。
- 计算各中心年OAR和EVAR手术量、30天择期手术死亡率及EVAR转为开放手术率,分别应用SVS指南标准确定符合指南的中心(CMAG)。
- 按地区(西部、中西部、南部、东北部)比较CMAG比例随年份的变化,使用χ2检验;采用多因素logistic回归调整地区后估计CMAG的时间趋势。
主要发现
- 全国EVAR CMAG比例每年增加1.7%,从2011年51.6%(n = 33/64)升至2019年67.1%(n = 190/283)(β = .05;95%CI 0.01-0.09;P = .02)。
- EVAR CMAG比例跨地区从2011年27.3%至66.7%变为2019年63.9%至72.9%。
- 全国OAR CMAG比例每年下降1.8%,从2011年32.8%(n = 21/64)降至2019年16.3%(n = 46/283)(β = -.14;95%CI -0.19至-0.10;P < .01)。
- 同时符合EVAR和OAR指南的CMAG比例每年下降1.5%,从2011年26.6%(n = 17/64)降至2019年13.1%(n = 37/283)(β = -.12;95%CI -0.17至-0.07;P < .01)。
- 2019年各地区同时符合EVAR和OAR指南的CMAG比例无显著差异(P = .82)。
关键数值与推荐
- SVS指南推荐EVAR应集中在年手术量≥10例且围手术期死亡率和转为开放手术率≤2%的中心。
- SVS指南推荐OAR应集中在年开放主动脉手术量≥10例且围手术期死亡率≤5%的中心。
- 同时符合EVAR和OAR指南的中心定义为同时满足上述两项标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Based on data supporting a volume-outcome relationship in elective aortic aneurysm repair, the Society of Vascular Surgery (SVS) guidelines recommend that endovascular aortic repair (EVAR) be localized to centers that perform ≥10 operations annually and have a perioperative mortality and conversion-to-open rate of ≤2% and that open aortic repair (OAR) be localized to centers that perform ≥10 open aortic operations annually and have a perioperative mortality ≤5%. However, the number and distribution of centers meeting the SVS criteria remains unclear. This study aimed to estimate the temporal trends and geographic distribution of Centers Meeting the SVS Aortic Guidelines (CMAG) in the United States. METHODS: The SVS Vascular Quality Initiative was queried for all OAR, aortic bypasses, and EVAR from 2011 to 2019. Annual OAR and EVAR volume, 30-day elective operative mortality for OAR or EVAR, and EVAR conversion-to-open rate for all centers were calculated. The SVS guidelines for OAR and EVAR, individually and combined, were applied to each institution leading to a CMAG designation. The proportion of CMAGs by region (West, Midwest, South, and Northeast) were compared by year using a χ2 test. Temporal trends were estimated using a multivariable logistic regression for CMAG, adjusting by region. RESULTS: Overall, 67,865 patients (49,264 EVAR; 11,010 OAR; 7591 aortic bypasses) at 336 institutions were examined. The proportion of EVAR CMAGs increased nationally by 1.7% annually from 51.6% (n = 33/64) in 2011 to 67.1% (n = 190/283) in 2019 (β = .05; 95% confidence interval [CI], 0.01-0.09; P = .02). The proportion of EVAR CMAGs across regions ranged from 27.3% to 66.7% in 2011 to 63.9% to 72.9% in 2019. In contrast, the proportion of OAR CMAGs has decreased nationally by 1.8% annually from 32.8% (n = 21/64) in 2011 to 16.3% (n = 46/283) in 2019 (β = -.14; 95% CI, -0.19 to -0.10; P < .01). Combined EVAR and OAR CMAGs were even less frequent and decreased by 1.5% annually from 26.6% (n = 17/64) in 2011 to 13.1% (n = 37/283) in 2019 (β = -.12; 95% CI, -0.17 to -0.07; P < .01). In 2019, there was no significant difference in regional variation of the proportion of combined EVAR and OAR CMAGs (P = .82). CONCLUSIONS: Although an increasing proportion of institutions nationally meet the SVS guidelines for EVAR, a smaller proportion meet them for OAR, with a concerning downward trend. These data question whether we can safely offer OAR at most institutions, have important implications about sufficient OAR exposure for trainees, and support regionalization of OAR.
引用
- Ramirez JL, Matthay ZA, Lancaster E, et al. Decreasing prevalence of centers meeting the Society for Vascular Surgery abdominal aortic aneurysm guidelines in the United States. J Vasc Surg. 2023. PMID: 37774990. doi:10.1016/j.jvs.2023.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。